Review of the clinical approach to the treatment of disruptive mood dysregulation disorder.
Hendrickson B, Girma M, Miller L.
Int Rev Psychiatry. 2020 May;32(3):202-211. doi: 10.1080/09540261.2019.1688260. Epub 2019 Nov 28.
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder.
Bond DJ, Hadjipavlou G, Lam RW, McIntyre RS, Beaulieu S, Schaffer A, Weiss M; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.
Ann Clin Psychiatry. 2012 Feb;24(1):23-37.
Chronobiological theories of mood disorder.
Zaki NFW, Spence DW, BaHammam AS, Pandi-Perumal SR, Cardinali DP, Brown GM.
Eur Arch Psychiatry Clin Neurosci. 2018 Mar;268(2):107-118. doi: 10.1007/s00406-017-0835-5. Epub 2017 Sep 11.
Gut microbiota in autism and mood disorders.
Mangiola F, Ianiro G, Franceschi F, Fagiuoli S, Gasbarrini G, Gasbarrini A.
World J Gastroenterol. 2016 Jan 7;22(1):361-8. doi: 10.3748/wjg.v22.i1.361.
The experience of mood disorder and substance use: An integrative review.
Crowe M, Inder M, Thwaites B.
J Psychiatr Ment Health Nurs. 2023 Jun;30(3):295-308. doi: 10.1111/jpm.12876. Epub 2022 Oct 8.
Schizoaffective Disorder in the DSM-5.
Malaspina D, Owen MJ, Heckers S, Tandon R, Bustillo J, Schultz S, Barch DM, Gaebel W, Gur RE, Tsuang M, Van Os J, Carpenter W.
Schizophr Res. 2013 Oct;150(1):21-5. doi: 10.1016/j.schres.2013.04.026. Epub 2013 May 23.
Creativity and Mood Disorder: A Systematic Review and Meta-Analysis.
Taylor CL.
Perspect Psychol Sci. 2017 Nov;12(6):1040-1076. doi: 10.1177/1745691617699653. Epub 2017 Sep 21.
Age, period, and cohort trends in mood disorder indicators and suicide-related outcomes in a nationally representative dataset, 2005-2017.
Twenge JM, Cooper AB, Joiner TE, Duffy ME, Binau SG.
J Abnorm Psychol. 2019 Apr;128(3):185-199. doi: 10.1037/abn0000410. Epub 2019 Mar 14.
Interictal Dysphoric Disorder: A disorder with distinct nosography or atypical symptomatology of mood disorders in people with epilepsy? Results from a systematic review.
Conforti H, Massanobu Maekawa R, Roberto Fernandes Lisboa J, Maria de Araújo Filho G.
Epilepsy Behav. 2023 Aug;145:109231. doi: 10.1016/j.yebeh.2023.109231. Epub 2023 Jun 8.
Critical exploration of co-occurring Attention-Deficit/Hyperactivity Disorder, mood disorder and Substance Use Disorder.
Regnart J, Truter I, Meyer A.
Expert Rev Pharmacoecon Outcomes Res. 2017 Jun;17(3):275-282. doi: 10.1080/14737167.2017.1351878. Epub 2017 Jul 13.
